High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial. [electronic resource]
Producer: 20180223Description: e388-97 p. digitalISSN:- 2352-3026
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carmustine -- administration & dosage
- Central Nervous System Neoplasms -- diagnosis
- Combined Modality Therapy
- Female
- Follow-Up Studies
- Hematopoietic Stem Cell Transplantation
- Humans
- Lymphoma, Non-Hodgkin -- diagnosis
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Prognosis
- Prospective Studies
- Rituximab -- administration & dosage
- Survival Rate
- Thiotepa -- administration & dosage
- Transplantation, Autologous
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.